Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Current Deferred Revenue: 2015-2024

Historic Current Deferred Revenue for Adma Biologics (ADMA) over the last 9 years, with Dec 2024 value amounting to $143,000.

  • Adma Biologics' Current Deferred Revenue fell 87.35% to $143,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $143,000, marking a year-over-year decrease of 87.35%. This contributed to the annual value of $143,000 for FY2024, which is 21.43% down from last year.
  • Latest data reveals that Adma Biologics reported Current Deferred Revenue of $143,000 as of FY2024, which was down 21.43% from $182,000 recorded in FY2023.
  • Adma Biologics' Current Deferred Revenue's 5-year high stood at $182,000 during FY2023, with a 5-year trough of $142,834 in FY2020.
  • In the last 3 years, Adma Biologics' Current Deferred Revenue had a median value of $143,000 in 2024 and averaged $156,000.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first climbed by 27.27% in 2023, then decreased by 21.43% in 2024.
  • Over the past 5 years, Adma Biologics' Current Deferred Revenue (Yearly) stood at $142,834 in 2020, then remained steady at $142,834 in 2021, then rose by 0.12% to $143,000 in 2022, then grew by 27.27% to $182,000 in 2023, then declined by 21.43% to $143,000 in 2024.